The US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for ...

Privately-held French drugmaker Servier has announced the inauguration of its first unit dedicated to the production of ...

The US Food and Drug Administration has received new reports of hematologic malignancies, including life-threatening cases of ...

Munich, Germany headquartered contract development and manufacturing organization (CDMO) Adragos Pharma has acquired Baccinex ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

The US Food and Drug Administration (FDA) yesterday announced its Fiscal Year 2025 Generic Drug User Fee Amendments (GDUFA).

Kronos Bio has announced a major restructuring, including significant workforce reductions, as it grapples with clinical and ...

Johnson & Johnson (J&J) has made significant strides in multiple myeloma treatment, with breakthroughs in targeted therapies ...

UK-based drugmaker Advanz Pharma has announced that following the grant of a temporary suspension, as announced on last month ...

The first iteration of the European Shortages Monitoring Platform (ESMP) has gone live. Using this version of the ESMP, marketing authorization holders (MAHs) can submit data to routinely report ...

San Diago, USA-based Acadia Pharmaceuticals yesterday announced it has entered into an exclusive worldwide license agreement with Denmark’s Saniona for the development and commercialization of SAN711, ...

The European Medicines Agency has approved Tevimbra (tislelizumab) in combination with chemotherapy for advanced throat and ...